Belief BioMed announced BBM-H901 (Dalnacogene Ponparvovec Injection), China's first hemophilia B gene therapy, was officially approved in Macao, China SHANGHAI, March 19, 2026 /PRNewswire/ — Belief BioMed ("BBM") today announced that… CISION PRNewswireMarch 19, 2026
Press ReleaseViettel Ranks No.1 Globally in Telecom Brand Strength HANOI, Vietnam, March 19, 2026 /PRNewswire/ — Viettel Group has been ranked… CISION PRNewswireMarch 19, 2026
Press ReleaseTech"MTR • Care App 2.0" by Cherrypicks and MTR Wins IAB Hong Kong Digital Awards 2025 — Best Use of AI & Technology Award-winning campaign recognised for revolutionizing inclusive travel experience for elderly and customers… CISION PRNewswireMarch 19, 2026
Press ReleaseAnalog Devices Strengthens Global Manufacturing Resilience with New Thailand Facility WILMINGTON, Mass. and CHONBURI, Thailand, March 19, 2026 /PRNewswire/ — Global semiconductor… CISION PRNewswireMarch 19, 2026
Canadian Solar Reports Fourth Quarter and Full Year 2025 Results KITCHENER, ON, March 19, 2026 /PRNewswire/ — Canadian Solar Inc. ("Canadian Solar"… CISION PRNewswireMarch 19, 2026
ZKH Group Limited Announces Fourth Quarter and Fiscal Year 2025 Unaudited Financial Results SHANGHAI, March 19, 2026 /PRNewswire/ — ZKH Group Limited ("ZKH" or the… CISION PRNewswireMarch 19, 2026
X Financial to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 26, 2026 SHENZHEN, China, March 19, 2026 /PRNewswire/ — X Financial (NYSE: XYF) (the… CISION PRNewswireMarch 19, 2026
China Unicom Free Cash Flow Up by Nearly 30% Highlights: Service revenue reached RMB 347.7 billion. Net profit[1] was RMB 20.8… CISION PRNewswireMarch 19, 2026